Effects Of Ciclesonide And Beclomethasone On Lens Opacification In Adult Subjects With Moderate To Severe Persistent Asthma
Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
The primary objective is to demonstrate the non-inferiority of ciclesonide compared to
beclomethasone-HFA in the occurrence of Class 1 lens event for nuclear (NO), cortical (C), or
posterior subcapsular (P) lens opacification within 12 months. Secondary objectives are to
compare ciclesonide and beclomethasone with respect to class II and class III best corrected
visual acuity and intraocular pressure from baseline to 12 months.